Reaction
Subretinal Fluid reporting signals
As of the last recalculation, Subretinal Fluid appears in 1,042 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 372.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 336 | 372.7 | 377.5 |
| Aflibercept | 272 | 235.3 | 237.4 |
| Faricimab | 41 | 105.2 | 105.7 |
| Irinotecan Hydrochloride | 36 | 57.9 | 58.0 |
| Encorafenib | 21 | 43.2 | 43.3 |
| Bevacizumab | 207 | 41.4 | 41.5 |
| Leucovorin Calcium | 37 | 40.1 | 40.1 |
| Guanfacine | 9 | 23.0 | 23.1 |
| Amphetamine | 7 | 17.0 | 17.0 |
| Ganciclovir Sodium | 8 | 15.2 | 15.2 |
| Timolol | 9 | 15.0 | 15.0 |
| Doxyclycline Hyclate | 12 | 14.2 | 14.2 |
| Fluorouracil Cream, 0.5% | 44 | 12.0 | 12.0 |
| Fluorouracil | 44 | 11.8 | 11.8 |